BAT-CAR-T and Private Cytokine Signaling CCR(Dynamic Cell Therapies)

N/A

Report date: 2024/09/02 10:38:52

Base Information

Drug NameBAT-CAR-T and Private Cytokine Signaling CCR(Dynamic Cell Therapies)

Drug Alias NameBAT-CAR-T and Private Cytokine Signaling Chimeric Cytokine Receptor(Dynamic Cell Therapies)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDynamic Cell Therapies Inc

China Registration ClassN/A

Develop Information

Active CompaniesDynamic Cell Therapies Inc

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A